Browse > Article

Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hyper-sensitivity in BALB/c mice  

Mahmoudzadeh-Niknam, Hamid (Immunology Department, Pasteur Institute of Iran)
Kiaei, Simin Sadat (Immunology Department, Pasteur Institute of Iran)
Iravani, Davood (Immunology Department, Pasteur Institute of Iran)
Publication Information
Parasites, Hosts and Diseases / v.45, no.2, 2007 , pp. 103-109 More about this Journal
Abstract
Leishmania tropica and L. major are etiologic agents of human cutaneous leishmaniasis. Delayed type hypersensitivity (DTH) is an immunologic response that has been frequently used as a correlate for protection against or sensitization to leishmania antigen. In BALB/c mice, L. tropica infection results in non-ulcerating disease, whereas L. major infection results in destructive lesions. In order to clarify the immunologic mechanisms of these 2 different outcomes, we compared the ability of these 2 leishmania species in induction of DTH response in this murine model. BALB/c mice were infected with L. major or L. tropica, and disease evolution and DTH responses were determined. The results show that the primary L. major infection can exacerbate the secondary L. major infection and is associated with DTH response. Higher doses of the primary L. major infection result in more disease exacerbation of the secondary L. major infection as well as higher DTH response. L. tropica infection induces lower DTH responses than L. major. We have previously reported that the primary L. tropica infection induces partial protection against the secondary L. major infection in BALB/c mice. Induction of lower DTH response by L. tropica suggests that the protection induced against L. major by prior L. tropica infection may be due to suppression of DTH response.
Keywords
Leishmania tropica; Leishmania major; leishmaniasis; delayed type hypersensitivity; BALB/c mice;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Abbas AK, Litchman AH (2004) Cellular and Molecular Immunology, 5th ed. pp 306-308, Elsevier Science (USA), Philadelphia, USA
2 Lira R, Mendez S, Carrera L, Jaffe C, Neva F, Sacks D (1998) Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease. Exp Parasitol 89: 331-342   DOI   ScienceOn
3 Courret N, Lang T, Milon G, Antoine JC (2003) Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. Int J Parasitol 33: 1373-1383   DOI   ScienceOn
4 Convit J, Ulrich M, Fernandez CT, Tapia FJ, Caceres-Dittmar G, Castes M, Rondon AJ (1993) The clinical and immunological spectrum of american cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 87: 444-448   DOI   ScienceOn
5 Babay BE, Louzir H, Kebaier C, Boubaker S, Dellagi K, Cazenave PA (2004) Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major. Infect Immun 72: 4603-4611   DOI   ScienceOn
6 Mahmoudzadeh-Niknam H (2004) Induction of partial protection against Leishmania major in BALB/c mice by Leishmania tropica. Scand J Lab Anim Sci 31: 201-207
7 Mahmoudzadeh-Niknam H, McKerrow JH (2004) Leishmania tropica: cysteine proteases are essential for growth and pathogenicity. Exp Parasitol 106: 158-163   DOI   ScienceOn
8 Liew FY, Dhaliwal JS (1987) Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites. J Immunol 138: 4450-4456   PUBMED
9 Dhaliwal JS, Liew FY (1987) Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis. Infect Immun 55: 645- 651   PUBMED
10 Dhaliwal JS, Liew FY, Cox FE (1985) Specific suppressor T cells for delayed-type hypersensitivity in susceptible mice immunized against cutaneous leishmaniasis. Infect Immun 49: 417-423
11 Doherty TM, Coffman RL (1996) Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Exp Parasitol 84: 124-135   DOI   ScienceOn
12 Saha B, Tonkal AMDJ, Croft S, Roy S (2004) Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis. Clin Exp Immunol 137: 19-23   DOI   ScienceOn
13 Howard JG, Hale C, Liew FY (1980) Immunologic regulation of experimental cutaneous leishmaniasis, III. Nature and significance of specific suppression of cell-mediated immunity. J Exp Med 152: 594-607   DOI   ScienceOn
14 Liew FY, Singleton A, Cillari E, Howard JG (1985) Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection. J Immunol 135: 2102-2107   PUBMED
15 Compton HL, Farrell JP (2002) CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major. J Immunol 168: 1302-1308   DOI   PUBMED
16 De Rossell RA, Bray RS, Alexander J (1987) The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis. Parasite Immunol 9: 105-115   DOI   ScienceOn
17 Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H (1992) Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 257: 539-542   DOI